Procter & Gamble Health Limited (NSE:PGHL)

India flag India · Delayed Price · Currency is INR
6,450.50
+134.00 (2.12%)
Sep 4, 2025, 3:29 PM IST
2.12%
Market Cap104.94B
Revenue (ttm)12.73B
Net Income (ttm)3.01B
Shares Outn/a
EPS (ttm)180.87
PE Ratio34.91
Forward PE32.59
Dividend185.00 (2.92%)
Ex-Dividend DateAug 22, 2025
Volume16,619
Average Volume15,697
Open6,317.50
Previous Close6,316.50
Day's Range6,317.50 - 6,550.00
52-Week Range4,863.00 - 6,739.00
Beta0.43
RSI55.06
Earnings DateNov 4, 2025

About Procter & Gamble Health

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble H... [Read more]

Sector Healthcare
Founded 1967
Employees 1,326
Stock Exchange National Stock Exchange of India
Ticker Symbol PGHL
Full Company Profile

Financial Performance

In 2024, Procter & Gamble Health's revenue was 12.18 billion, an increase of 5.80% compared to the previous year's 11.51 billion. Earnings were 2.51 billion, an increase of 24.98%.

Financial Statements

News

P&G Health shares surge 8% as Q1 revenue jumps 19.5% YoY to Rs 339 crore

Shares of Procter & Gamble Health surged over 8% on Friday following the company’s robust financial performance in the first quarter of FY26. The stock touched a high of ₹6,476, rising sharply from th...

4 weeks ago - Business Upturn

P&G Health Q2 FY25: Revenue rises 2.8% YoY to Rs 313.41 crore, net profit surges 25.6% to Rs 82.33 crore

Procter & Gamble Health Limited has reported its unaudited financial results for the quarter ended September 30, 2024, showing steady revenue growth and a notable increase in profitability. For Q2 FY2...

10 months ago - Business Upturn

Procter & Gamble Health Q2 FY25 results: Stock jumps 2% ahead of result announcement

Procter & Gamble Health shares have experienced a notable increase, jumping more than 2% ahead of Q2 FY25 results. The stock opened at Rs 5,367.70, reaching a high of Rs 5,380.00 during trading hours,...

10 months ago - Business Upturn